March 20, 2018 — Febuxostat, a gout drug that has been in use for nearly a decade, was found to significantly increase ...

March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack ...

March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the more ...

March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...

March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who received ...

The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy (DAPT) for either six months or at least 12 months after receiving a drug-eluting stent. Patients who were given DAPT for only six months, however, had more than double the risk of a heart attack compared with those treated for at least 12 months, according to research presented at the American College of Cardiology’s (ACC) 67th Annual Scientific Session, March 10-12 in Orlando, Fla.